Precision Medicine Executive - Mid Atlantic

Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing.

About the role

The Precision Medicine Executive (PME) will serve as a critical member of the Customer Engagement Team and will have an exciting opportunity within Cogent’s Precision Medicine organization as we prepare for our first product launch. The Precision Medicine Executive (PME) is charged with embedding Cogent within some of the most influential healthcare systems across the United States. The Cogent PME role is best described as a hybrid Regional Diagnostic Expert and Thought Leader